What is it about?
What is known about this subject? • Lung-transplant recipients often develop acute kidney injury evolving into chronic kidney disease increasing both morbidity and mortality • To date, the pathophysiology of acute kidney injury after lung transplantation has not been fully elucidated • The immunosuppressant tacrolimus, which is nephrotoxic, is difficult to dose in the unstable clinical setting What this study adds: • Supra-therapeutic whole-blood tacrolimus trough concentrations are related to the emergence of acute kidney injury in the first days after lung transplantation • Supra-therapeutic whole-blood tacrolimus trough concentrations often occur early after lung transplantation • AKI after lung transplantation shows low recovery rates and often evolves to severe chronic kidney
Featured Image
Perspectives
Read the Original
This page is a summary of: High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury, European Journal of Clinical Pharmacology, January 2017, Springer Science + Business Media,
DOI: 10.1007/s00228-017-2204-8.
You can read the full text:
Contributors
The following have contributed to this page